Indication
Hospitalized
2 clinical trials
3 products
Product
RitonavirProduct
NirmatrelvirClinical trial
AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED NIRMATRELVIR/RITONAVIR COMPARED WITH PLACEBO/RITONAVIR FOR THE TREATMENT OF SEVERE COVID-19 IN HOSPITALIZED PARTICIPANTS WHO ARE IMMUNOCOMPROMISED OR AT INCREASED RISK FOR SEVERE COVID-19 OUTCOMESStatus: Withdrawn, Estimated PCD: 2023-09-21
Clinical trial
Pharmacological and Non-pharmachological Interventions in Management of Peripheral Venipuncture Related Pain: a Randomized Clinical TrialStatus: Completed, Estimated PCD: 2020-04-30
Product
EMLA